Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Cash (2020 - 2026)

Journey Medical filings provide 6 years of Change in Cash readings, the most recent being -$858000.0 for Q4 2025.

  • On a quarterly basis, Change in Cash rose 60.2% to -$858000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 million, a 153.06% increase, with the full-year FY2025 number at $3.8 million, up 153.06% from a year prior.
  • Change in Cash hit -$858000.0 in Q4 2025 for Journey Medical, down from $4.7 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $27.4 million in Q4 2021 to a low of -$9.1 million in Q2 2023.
  • Median Change in Cash over the past 5 years was -$1.2 million (2024), compared with a mean of $792200.0.
  • Biggest five-year swings in Change in Cash: skyrocketed 527.25% in 2021 and later tumbled 435.86% in 2025.
  • Journey Medical's Change in Cash stood at $27.4 million in 2021, then tumbled by 110.54% to -$2.9 million in 2022, then soared by 193.14% to $2.7 million in 2023, then plummeted by 180.15% to -$2.2 million in 2024, then surged by 60.2% to -$858000.0 in 2025.
  • The last three reported values for Change in Cash were -$858000.0 (Q4 2025), $4.7 million (Q3 2025), and -$777000.0 (Q2 2025) per Business Quant data.